Lack of influence of c-Ha-ras expression on the drug sensitivity of human bladder cancer histocultured in three-dimensions

Anticancer Res. 1993 Jul-Aug;13(4):941-6.

Abstract

The mechanism of drug resistance in human cancers is complex. In addition to overexpression of a series of multiple-drug-resistance genes, there has been the suggestion that the Ha-ras gene may participate in conferring resistance. In this study, a series of three human-bladder carcinoma cell lines were studied, one parental type, one transfected by wild-type Ha-ras and another transfected by mutant Ha-ras. The ras gene was overexpressed in the latter two cell lines which also were more invasive than the parental when injected as individual cells in the nude-mouse bladder. The results described here have indicated that the ras-gene expression level or mutational status did not affect drug resistance when the tumor lines were histocultured as three-dimensional tissue on collagen-sponge-gels. The drug-response spectrum of the histocultured lines qualitatively reflected a clinical experience although all lines were relatively drug resistant, possibly reflecting their three-dimensional configuration in culture.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents / toxicity*
  • Cell Division / drug effects
  • Cisplatin / therapeutic use
  • Cisplatin / toxicity
  • DNA, Neoplasm / biosynthesis
  • Dactinomycin / therapeutic use
  • Dactinomycin / toxicity
  • Drug Resistance / genetics*
  • Gene Expression
  • Genes, ras*
  • Humans
  • Mice
  • Mice, Nude
  • Mitomycin / therapeutic use
  • Mitomycin / toxicity
  • Mutagenesis
  • Neoplasm Transplantation
  • Thymidine / metabolism
  • Transfection
  • Transplantation, Heterologous
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / pathology*
  • Vincristine / therapeutic use
  • Vincristine / toxicity

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Dactinomycin
  • Mitomycin
  • Vincristine
  • Cisplatin
  • Thymidine